Literature DB >> 27992963

Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.

Nobuyasu Awano1,2, Minoru Inomata3, Soichiro Ikushima2, Daisuke Yamada4, Masatoshi Hotta4, Shunji Tsukuda4, Toshio Kumasaka5, Tamiko Takemura5, Yoshinobu Eishi1.   

Abstract

AIMS: To evaluate pulmonary vasculopathy in an autopsy series of patients with combined pulmonary fibrosis and emphysema (CPFE), and compare these findings with those of patients with idiopathic pulmonary fibrosis (IPF) alone and emphysema alone. METHODS AND
RESULTS: We retrospectively analysed the clinical, radiological and pathological features of 26 patients with CPFE, 11 with IPF, and 23 with emphysema. We evaluated pulmonary vascular, venous-venular and arteriolar tissue changes in the fibrotic, emphysematous and relatively unaffected (preserved) areas by using the Heath-Edwards scoring system. We found moderate-to-severe vasculopathy in the CPFE group, but no significant differences in the fibrotic and emphysematous areas among the three groups. However, in the preserved area, the grading was significantly different among the three groups (P < 0.001), and vasculopathy in the CPFE group was the most severe. Although venous-venular and arteriolar changes in almost all fibrotic and emphysematous areas in the three groups showed no significant differences, there were significant differences in venous-venular (P = 0.004) and arteriolar (P < 0.001) changes in the preserved area among the three groups, which were most prevalent in the CPFE group. In the CPFE group, venous-venular changes and vasculopathy by Heath-Edwards grading were highest in the fibrotic area and lowest in the preserved area.
CONCLUSIONS: These results imply that pulmonary vasculopathy in patients with CPFE could occur in the whole lung tissue. This may explain the tendency for it to lead to the development of pulmonary hypertension in CPFE cases.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  combined pulmonary fibrosis and emphysema; emphysema; idiopathic pulmonary fibrosis; pulmonary hypertension; vasculopathy

Mesh:

Year:  2017        PMID: 27992963     DOI: 10.1111/his.13153

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis.

Authors:  Grégoire Ruffenach; Ellen O'Connor; Mylène Vaillancourt; Jason Hong; Nancy Cao; Shervin Sarji; Shayan Moazeni; Jeremy Papesh; Victor Grijalva; Christine M Cunningham; Le Shu; Arnab Chattopadhyay; Shuchita Tiwari; Olaf Mercier; Frédéric Perros; Soban Umar; Xia Yang; Aldrin V Gomes; Alan M Fogelman; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.

Authors:  William D Cornwell; Cynthia Kim; Alejandra C Lastra; Chandra Dass; Sudhir Bolla; He Wang; Huaqing Zhao; Frederick V Ramsey; Nathaniel Marchetti; Thomas J Rogers; Gerard J Criner
Journal:  Biomarkers       Date:  2018-11-19       Impact factor: 2.658

Review 3.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

4.  Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation.

Authors:  Yaniv Dotan; Jeffrey Stewart; Andrew Gangemi; He Wang; Amandeep Aneja; Bhaidharbi Chakraborty; Chandra Dass; Huaqing Zhao; Nathaniel Marchetti; Gilbert D'Alonzo; Francis C Cordova; Gerard Criner; Albert James Mamary
Journal:  BMJ Open Respir Res       Date:  2020-07

5.  Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia.

Authors:  Hideaki Yamakawa; Tamiko Takemura; Tomohisa Baba; Takashi Ogura
Journal:  Respir Med Case Rep       Date:  2018-09-13

6.  Use of machine learning models to predict prognosis of combined pulmonary fibrosis and emphysema in a Chinese population.

Authors:  Qing Liu; Di Sun; Yu Wang; Pengfei Li; Tianci Jiang; Lingling Dai; Mengjie Duo; Ruhao Wu; Zhe Cheng
Journal:  BMC Pulm Med       Date:  2022-08-29       Impact factor: 3.320

7.  Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.

Authors:  Rahul Sangani; Andrew Ghio; Stacey Culp; Zalak Patel; Sunil Sharma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-21

8.  Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?

Authors:  Hideaki Yamakawa; Tamiko Takemura; Tae Iwasawa; Yumie Yamanaka; Satoshi Ikeda; Akimasa Sekine; Hideya Kitamura; Tomohisa Baba; Shinichiro Iso; Koji Okudela; Kazuyoshi Kuwano; Takashi Ogura
Journal:  BMC Pulm Med       Date:  2018-01-30       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.